Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs

Author

Céspedes, María Virtudes

Fernández Caparrós, Yolanda

Unzueta Elorza, Ugutz

Mendoza, Rosa

Seras-Franzoso, Joaquin

Sánchez Chardi, Alejandro

Álamo, Patricia

Toledo-Rubio, Verónica

Ferrer-Miralles, Neus

Vázquez Gómez, Esther

Schwartz, Simon

Abasolo, Ibane

Corchero Nieto, José Luis

Mangues, Ramon

Villaverde Corrales, Antonio,

Universitat Autònoma de Barcelona

Publication date

2016

Abstract

Altres ajuts: MARATOTV3/2013/3930


In the human endocrine system many protein hormones including urotensin, glucagon, obestatin, bombesin and secretin, among others, are supplied from amyloidal secretory granules. These granules form part of the so called functional amyloids, which within the whole aggregome appear to be more abundant than formerly believed. Bacterial inclusion bodies (IBs) are non-toxic, nanostructured functional amyloids whose biological fabrication can be tailored to render materials with defined biophysical properties. Since under physiological conditions they steadily release their building block protein in a soluble and functional form, IBs are considered as mimetics of endocrine secretory granules. We have explored here if the in vivo implantation of functional IBs in a given tissue would represent a stable local source of functional protein. Upon intratumoral injection of bacterial IBs formed by a potent protein ligand of CXCR4 we have observed high stability and prevalence of the material in absence of toxicity, accompanied by apoptosis of CXCR4+ cells and tumor ablation. Then, the local immobilization of bacterial amyloids formed by therapeutic proteins in tumors or other tissues might represent a promising strategy for a sustained local delivery of protein drugs by mimicking the functional amyloidal architecture of the mammals' endocrine system.

Document Type

Article

Language

English

Subjects and keywords

Inclusion-bodies; Escherichia-coli; Cell-proliferation; Controlled-release; Sustained-release; Delivery; Amyloids; Therapeutics; Aggregation; Scaffolds

Publisher

 

Related items

Ministerio de Economía y Competitividad BIO2013-41019-P

Agència de Gestió d'Ajuts Universitaris i de Recerca 2014/SGR-132

Agència de Gestió d'Ajuts Universitaris i de Recerca 2014/PROD0005

Scientific reports ; Vol. 6 Núm. 35765 (October 2016), p. 1-10

Rights

open access

Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.

https://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)